About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Philadelphia | 133 Studies

Clinical Trials EpilepsyPhiladelphia

Epilepsy Clinical Trials in Philadelphia

Find 133 clinical trials for epilepsy near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-133 of 133 trials

TerminatedStudy to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersThe purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.NCT01390220·Phoenix, Arizona and 89 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedA Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset SeizuresThe study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3…NCT00465517·Birmingham, Alabama and 26 others

RecruitingA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as…NCT05667142·Mobile, Alabama and 137 others

CompletedEfficacy of YKP3089 in Patients With Photosensitive EpilepsyThe aim of this study is to evaluate the ability of a single oral dose of YKP3089 to abolish or clearly reduce the IPS-induced photo-paroxysmal EEG response in photosensitive…NCT00616148·Baltimore, Maryland and 3 others

CompletedClobazam in Patients With Lennox-Gastaut SyndromeThe purpose of this study is to evaluate the safety and efficacy of clobazam as adjunctive therapy in the treatment of seizures which lead to drop attacks (drop seizures) in…NCT00518713·Huntsville, Alabama and 52 others

CompletedEfficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial SeizuresThe purpose of this study is to determine whether Eslicarbazepine acetate (BIA 2-093) is an effective adjunct therapy in the treatment of refractory partial seizuresNCT00988429·Mobile, Alabama and 161 others

RecruitingEpilepsy Learning Healthcare System (ELHS)The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy.NCT06265103·Phoenix, Arizona and 12 others

CompletedRufinamide Given as Adjunctive Therapy in Participants With Refractory Partial SeizuresTo evaluate the effect of rufinamide on total partial seizure frequency in adolescent and adult participants (12 to 80 years, inclusive) with refractory partial onset seizures…NCT00334958·Mobile, Alabama and 76 others

CompletedCX-8998 for Absence SeizuresThis is a Phase 2a, open-label study consisting of a screening period of up to 4 weeks and a 4-dose-titration treatment period to a dose of up to 10 mg twice daily (BID) of…NCT03406702·Little Rock, Arkansas and 6 others

RecruitingStudy Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures.NCT07563881·Palmdale, California and 16 others

CompletedA Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial SeizuresThe purpose of this study was to evaluate the safety and pharmacokinetics of LCM syrup in children ages from 1 month to 17 years with uncontrolled partial seizures when added to 1…NCT00938431·Sacramento, California and 20 others

CompletedA Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresThe X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101…NCT05614063·Mobile, Alabama and 124 others

CompletedTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.NCT00141336·Phoenix, Arizona and 102 others

PreviousPage 7 of 7

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia